308 related articles for article (PubMed ID: 24797310)
1. Strategy to enhance the therapeutic effect of doxorubicin in human hepatocellular carcinoma by selenocystine, a synergistic agent that regulates the ROS-mediated signaling.
Fan C; Zheng W; Fu X; Li X; Wong YS; Chen T
Oncotarget; 2014 May; 5(9):2853-63. PubMed ID: 24797310
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo.
Fan C; Zheng W; Fu X; Li X; Wong YS; Chen T
Cell Death Dis; 2014 Apr; 5(4):e1191. PubMed ID: 24763048
[TBL] [Abstract][Full Text] [Related]
3. Selenocystine potentiates cancer cell apoptosis induced by 5-fluorouracil by triggering reactive oxygen species-mediated DNA damage and inactivation of the ERK pathway.
Fan C; Chen J; Wang Y; Wong YS; Zhang Y; Zheng W; Cao W; Chen T
Free Radic Biol Med; 2013 Dec; 65():305-316. PubMed ID: 23837948
[TBL] [Abstract][Full Text] [Related]
4. Selenocystine inhibits JEG-3 cell growth
Zhao M; Hou Y; Fu X; Li D; Sun J; Fu X; Wei Z
J Cancer Res Ther; 2018; 14(7):1540-1548. PubMed ID: 30589036
[TBL] [Abstract][Full Text] [Related]
5. Longikaurin A, a natural ent-kaurane, induces G2/M phase arrest via downregulation of Skp2 and apoptosis induction through ROS/JNK/c-Jun pathway in hepatocellular carcinoma cells.
Liao YJ; Bai HY; Li ZH; Zou J; Chen JW; Zheng F; Zhang JX; Mai SJ; Zeng MS; Sun HD; Pu JX; Xie D
Cell Death Dis; 2014 Mar; 5(3):e1137. PubMed ID: 24651440
[TBL] [Abstract][Full Text] [Related]
6. DMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivo.
Yao S; Ye J; Yin M; Yu R
Cancer Lett; 2020 Jul; 483():87-97. PubMed ID: 32268165
[TBL] [Abstract][Full Text] [Related]
7. Lappaconitine Sulfate Inhibits Proliferation and Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells through the Reactive Oxygen Species-Dependent Mitochondrial Pathway.
Zhang X; Ma J; Song N; Guo Y; Hui L; Sang C
Pharmacology; 2020; 105(11-12):705-714. PubMed ID: 32062649
[TBL] [Abstract][Full Text] [Related]
8. Oxymatrine synergistically enhances the inhibitory effect of 5-fluorouracil on hepatocellular carcinoma in vitro and in vivo.
Liu Y; Bi T; Dai W; Wang G; Qian L; Gao Q; Shen G
Tumour Biol; 2016 Jun; 37(6):7589-97. PubMed ID: 26687645
[TBL] [Abstract][Full Text] [Related]
9. (-)-Epigallocatechin-3-gallate Down-regulates Doxorubicin-induced Overexpression of P-glycoprotein Through the Coordinate Inhibition of PI3K/Akt and MEK/ERK Signaling Pathways.
Satonaka H; Ishida K; Takai M; Koide R; Shigemasa R; Ueyama J; Ishikawa T; Hayashi K; Goto H; Wakusawa S
Anticancer Res; 2017 Nov; 37(11):6071-6077. PubMed ID: 29061787
[TBL] [Abstract][Full Text] [Related]
10. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC.
Choi J; Yip-Schneider M; Albertin F; Wiesenauer C; Wang Y; Schmidt CM
J Surg Res; 2008 Dec; 150(2):219-26. PubMed ID: 18468633
[TBL] [Abstract][Full Text] [Related]
11. Investigation of prunetrin induced G2/M cell cycle arrest and apoptosis via Akt/mTOR/MAPK pathways in hepatocellular carcinoma cells.
Abusaliya A; Bhosale PB; Kim HH; Park MY; Jeong SH; Lee S; Kim GS
Biomed Pharmacother; 2024 May; 174():116483. PubMed ID: 38552440
[TBL] [Abstract][Full Text] [Related]
12. Enhanced anticancer efficiency of doxorubicin against human glioma by natural borneol through triggering ROS-mediated signal.
Cao WQ; Li Y; Hou YJ; Yang MX; Fu XQ; Zhao BS; Jiang HM; Fu XY
Biomed Pharmacother; 2019 Oct; 118():109261. PubMed ID: 31374355
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib--the role of extracellular signal-regulated kinase counteraction.
Manov I; Pollak Y; Broneshter R; Iancu TC
FEBS J; 2011 Sep; 278(18):3494-507. PubMed ID: 21790999
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cancer cell growth by oleanolic acid in multidrug resistant liver carcinoma is mediated via suppression of cancer cell migration and invasion, mitochondrial apoptosis, G2/M cell cycle arrest and deactivation of JNK/p38 signalling pathway.
Gao C; Li X; Yu S; Liang L
J BUON; 2019; 24(5):1964-1969. PubMed ID: 31786862
[TBL] [Abstract][Full Text] [Related]
15. β-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38/ERK MAPK signaling in human hepatocellular carcinoma.
Zhang G; He J; Ye X; Zhu J; Hu X; Shen M; Ma Y; Mao Z; Song H; Chen F
Cell Death Dis; 2019 Mar; 10(4):255. PubMed ID: 30874538
[TBL] [Abstract][Full Text] [Related]
16. Pentoxifylline induces apoptosis of HepG2 cells by reducing reactive oxygen species production and activating the MAPK signaling.
Wang Y; Dong L; Li J; Luo M; Shang B
Life Sci; 2017 Aug; 183():60-68. PubMed ID: 28583366
[TBL] [Abstract][Full Text] [Related]
17. Selenocystine induces apoptosis of A375 human melanoma cells by activating ROS-mediated mitochondrial pathway and p53 phosphorylation.
Chen T; Wong YS
Cell Mol Life Sci; 2008 Sep; 65(17):2763-75. PubMed ID: 18661100
[TBL] [Abstract][Full Text] [Related]
18. Autophagy inhibition contributes to the synergistic interaction between EGCG and doxorubicin to kill the hepatoma Hep3B cells.
Chen L; Ye HL; Zhang G; Yao WM; Chen XZ; Zhang FC; Liang G
PLoS One; 2014; 9(1):e85771. PubMed ID: 24465696
[TBL] [Abstract][Full Text] [Related]
19. Glutamate release inhibitor, Riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production.
Seol HS; Lee SE; Song JS; Lee HY; Park S; Kim I; Singh SR; Chang S; Jang SJ
Cancer Lett; 2016 Nov; 382(2):157-165. PubMed ID: 27612558
[TBL] [Abstract][Full Text] [Related]
20. Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent.
You ML; Chen YJ; Chong QY; Wu MM; Pandey V; Chen RM; Liu L; Ma L; Wu ZS; Zhu T; Lobie PE
Oncotarget; 2017 Jun; 8(24):39323-39344. PubMed ID: 28445151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]